Immobilization of heparin/poly-l-lysine nanoparticles on dopamine-coated surface to create a heparin density gradient for selective direction of platelet and vascular cells behavior

Windecker, 2007, Late coronary stent thrombosis, Circulation, 116, 1952, 10.1161/CIRCULATIONAHA.106.683995 Byrne, 2009, A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents, Eur Heart J, 30, 923, 10.1093/eurheartj/ehp044 Li, 2011, The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization, Biomaterials, 32, 4691, 10.1016/j.biomaterials.2011.03.025 Yang, 2010, The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility, Biomaterials, 31, 2072, 10.1016/j.biomaterials.2009.11.091 Guo, 2010, Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents, Acta biomater, 6, 534, 10.1016/j.actbio.2009.07.013 Bjork, 1982, Mechanism of the anticoagulant action of heparin, Mol Cell Biochem, 48, 161, 10.1007/BF00421226 Cindhuchao, 2003, Heparin inhibits SMC growth in the presence of human and fetal bovine serum, Biochem Biophys Res Commun, 302, 84, 10.1016/S0006-291X(03)00068-8 Hoshi, 2013, The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts, Biomaterials, 34, 30, 10.1016/j.biomaterials.2012.09.046 Guyton, 1980, Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin, Circ Res, 46, 625, 10.1161/01.RES.46.5.625 Ahn, 1999, Preventive effects of the heparin-coated stent on restenosis in the porcine model, Catheter Cardiovasc Interv, 48, 324, 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K Serruys, 1998, Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II), Lancet, 352, 673, 10.1016/S0140-6736(97)11128-X Boyle, 1964, Heparin in the treatment of chronic obstructive bronchopulmonary disease, Am J Cardiol, 14, 25, 10.1016/0002-9149(64)90100-6 Fine, 1968, Objective evaluation of heparin in the treatment of asthma, Am Rev Respir Dis, 98, 886 Conrad, 1998 Yu, 2012, The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration, Biomaterials, 33, 8062, 10.1016/j.biomaterials.2012.07.042 Cariou, 1988, Inhibition of human endothelial cell proliferation by heparin and steroids, Cell Biol Int Rep, 12, 1037, 10.1016/0309-1651(88)90028-8 Khorana, 2003, Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight, Arterioscler Thromb Vasc Biol, 23, 2110, 10.1161/01.ATV.0000090671.56682.D7 Yang, 2012, The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization, Biomaterials, 33, 6615, 10.1016/j.biomaterials.2012.06.055 Sakiyama-Elbert, 2013, Incorporation of heparin into biomaterials, Acta Biomater, 10, 1581, 10.1016/j.actbio.2013.08.045 Wang, 2003, Covalent immobilization of chitosan and heparin on PLGA surface, Int J Biol Macromol, 33, 95, 10.1016/S0141-8130(03)00072-2 Liu, 2013, Influence of a layer-by-layer-assembled multilayer of anti-CD34 antibody, vascular endothelial growth factor, and heparin on the endothelialization and anticoagulation of titanium surface, J Biomed Mater Res A, 101, 1144, 10.1002/jbm.a.34392 Lee, 2012, Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity, Acta Biomater, 8, 2549, 10.1016/j.actbio.2012.03.030 Zhang, 2002, A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies, Anal Biochem, 304, 271, 10.1006/abio.2002.5617 Chen, 2005, Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer, Biomaterials, 26, 7418e24, 10.1016/j.biomaterials.2005.05.053 Tsai, 2011, Poly(dopamine) coating of scaffolds for articular cartilage tissue engineering, Acta Biomater, 7, 4187, 10.1016/j.actbio.2011.07.024 Joddar, 2013, Sustained delivery of siRNA from dopamine-coated stainless steel surfaces, Acta Biomater, 9, 6753, 10.1016/j.actbio.2013.01.007 Yang, 2012, Mussel-inspired coating of polydopamine directs endothelial and smooth muscle cell fate for re-endothelialization of vascular devices, Adv Healthc Mater, 1, 548, 10.1002/adhm.201200073 Weng, 2011, Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents, Biomaterials, 32, 1253, 10.1016/j.biomaterials.2010.10.039 Park, 2008, Triple constructs consisting of nanoparticles and microspheres for bone-marrow-derived stromal-cell-delivery microscaffolds, Small, 4, 1950, 10.1002/smll.200701315 Merdan, 2002, Prospects for cationic polymers in gene and oligonucleotide therapy against cancer, Adv Drug Deliv Rev, 54, 715, 10.1016/S0169-409X(02)00046-7 Smith, 1980, Colorimetric method for the assay of heparin content in immobilized heparin preparations, Anal Biochem, 109, 466, 10.1016/0003-2697(80)90679-X Hamerli, 2003, Surface properties of and cell adhesion onto allylamine–plasma-coated polyethylenterephtalat membranes, Biomaterials, 24, 3989, 10.1016/S0142-9612(03)00312-0 Li, 2010, Oriented immobilization of anti-CD34 antibody on titanium surface for self-endothelialization induction, J Biomed Mater Res A, 94, 1283 Hanaor, 2012, The effects of carboxylic acids on the aqueous dispersion and electrophoretic deposition of ZrO2, J Eur Ceram Soc, 32, 235, 10.1016/j.jeurceramsoc.2011.08.015 Monchaux, 2010, Effects of surface properties and bioactivation of biomaterials on endothelial cells, Front Biosci (Schol Ed), 2, 239, 10.2741/s61 Hattori, 1989, Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140, J Biol Chem, 264, 7768, 10.1016/S0021-9258(18)83104-0 Olson, 1991, Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects, J Biol Chem, 26, 6353, 10.1016/S0021-9258(18)38125-0 Olson, 1992, Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement, J Biol Chem, 267, 12528, 10.1016/S0021-9258(18)42309-5 Moncada, 1997, Nitric oxide in the vasculature: physiology and pathophysiology, Ann N Y Acad Sci, 811, 60, 10.1111/j.1749-6632.1997.tb51989.x Thum, 2005, Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine, J Am Coll Cardiol, 46, 1693, 10.1016/j.jacc.2005.04.066 Červinka P, Bystroň M, Špaček R, Kvašňák M, Jakabčin J. Randomized Comparison of Genous Stent Versus Chromium-Cobalt stent for Treatment of ST-Elevation Myocardial Infarction. 6-month Clinical, Angiographic and IVUS Follow-up. GENIUS-STEMI trial. Presented at the American College of Cardiology Annual Scientific Session 2009. Lee, 2007, Mussel-inspired surface chemistry for multifunctional coatings, Science, 318, 426, 10.1126/science.1147241 Lee, 2009, Facile conjugation of biomolecules onto surfaces via Mussel adhesive protein inspired coatings, Adv Mater, 21, 431, 10.1002/adma.200801222 Joung, 2012, In situ forming, metal-adhesive heparin hydrogel surfaces for blood-compatible coating, Colloids Surf B Biointerfaces, 99, 102, 10.1016/j.colsurfb.2011.10.047 Jung, 2012, Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model, Biomaterials, 33, 295, 10.1016/j.biomaterials.2011.09.051 Dai, 2011, Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery, Biomaterials, 32, 1694, 10.1016/j.biomaterials.2010.10.044 Zhou, 2012, Glycopolymer modification on physicochemical and biological properties of poly(l-lysine) for gene delivery, Int J Biol Macromol, 50, 965, 10.1016/j.ijbiomac.2012.02.021 Yamagata, 2007, Structural advantage of dendritic poly(l-lysine) for gene delivery into cells, Bioorg Med Chem, 15, 526, 10.1016/j.bmc.2006.09.033 Lakshmi, 2010, Controlled release of 2, 3 desulfated heparin exerts its anti-inflammatory activity by effectively inhibiting E-selectin, J Biomed Mater Res A, 95, 118, 10.1002/jbm.a.32791 Gomes, 2006, Coronary stenting and inflammation: implications for further surgical and medical treatment, Ann Thorac Surg, 81, 1918, 10.1016/j.athoracsur.2005.10.014 Haery, 2004, Drug-eluting stents: the beginning of the end of restenosis?, Cleve Clin J Med, 71, 815, 10.3949/ccjm.71.10.815 Rossini, 2013, Oral antiplatelet therapy after drug-eluting stent implantation: adherence and side-effects, J Cardiovasc Med (Hagerstown), 14, 81, 10.2459/JCM.0b013e328356a545 Verheye, 2009, The GENESIS (randomized, multicenter study of the pimecrolimus-eluting and pimecrolimus/paclitaxel-eluting coronary stent system in patients with de novo lesions of the native coronary arteries) trial, JACC Cardiovasc Interv, 2, 205, 10.1016/j.jcin.2008.12.011 Adriaenssens, 2007, Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial, J Am Coll Cardiol, 49, 1265, 10.1016/j.jacc.2007.02.021 Wessely, 2010, New drug-eluting stent concepts, Nat Rev Cardiol, 7, 194, 10.1038/nrcardio.2010.14